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Abstract:
Here is the report of an environment friendly, rapid, and convenient one-pot ultrasound-promoted 
synthesis of 5-amino-2-(4-chlorophenyl)-7- substituted phenyl-8,8a-dihydro-7H-[1,3,4]thiadiazolo[3,2-
a]pyrimidine-6-carbonitrile derivatives. Multi-component reactions are useful for the creation of 
chemical libraries of drug-like compounds with levels of molecular complexity and diversity. 1,3,4-
Thiadiazolo[3,2-a]pyrimidine skeleton belongs to a well-known and important class of fused 
heterocycles prevalent in a number of natural products of biological activities including antitumor, 
fungicidal, antibacterial, and herbicidal, hence, prompted us to synthesis 1,3,4-Thiadiazolo[3,2-
a]pyrimidines. The final ten derivatives were obtained in excellent yield through a one-pot, three 
component condensation reaction of aldehyde, 4-chlorophenyl-2-aminothiadiazole, and malononitrile in 
10-12 ml of ethanol as solvent and sodium hydroxide as a catalyst. (VCX 500-220, Ultrasound Solid 
probe, irradiation at 800C and 20% amplitude).
We have carried out the same reaction by conventional method, whic  requires 9-10 hrs of refluxing 
and yield is lesser. Because of the advantage of faster reaction rates and better yields, use of Ultrasound 
solid probe, was found to be more suitable for this reaction. Structure of the synthesized derivatives was 
confirmed by IR, NMR and Mass spectral study.
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Heterocyclic compounds have drawn special attention in organic chemistry because of their
abundance in
natural products and their diverse biological properties [1]. During recent years there have been
intense investigations on fused thiadiazole and pyrimidine systems. Literature survey revealed
that [1,3,4] thiadiazolo[3,2-a]pyrimidine nucleus is associated with diverse pharmacodynamic
and chemotherapeutic activities [2,3], including antimicrobial [4,5,6] and antitumor activities [4,
6], herbicidal, antifungal, neuramidase inhibitors. 1,3,4-thiadiazolo[3,2-a]pyrimidines have
been used as key building blocks for the preparation of a variety of novel bioactive agents.[7]
The conventional multistep methods for the preparation of cmplex molecules
involve large synthetic operations, including extractiona d purification processes for each
individual step,that leadto syntheticinefficiencyandthegenerationof largeamountsof waste.
So designing multicomponent reactions (MCRs) in one pot andcreation of several bonds in a
single operation are the major challenge for modern organicchemistry. Multicomponent
reactions (MCRs) are chemical transformations in which three or more different starting




reduction in overall reaction time
operational simplicity
Less or no generation of waste
No individual step extraction and purification processes
less amount of solvents required
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Green chemistry has become a major inspiration for organic chemists to develop environmentally benign 
routes for synthesis of organic compounds of biological values. For instance, performing reactions under 
ultrasonic irradiation due to the formation of high energy intermediates to enhance the reaction efficiency 
from both economical and ecological points has significant synthetic value and received great attention. 
In recent years, ultrasound has been extensively applied as a fantastic tool for different types of 
chemical reactions [8]
Ultrasound-promoted synthesis has various advantages over conventional synthesis techniques 
highly accelerated reaction rate, 
reasonable good yields, 
simple open systems, 
very less amount of solvents required ,
eco friendly method ,
clean heating system, neat and clean synthetic protocol, 
cheaper reagents and 
less extreme physical conditions ,
control on reaction parameters, 
milder reaction conditions.
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Mechanism of ulrasound irradiation in synthesis:
The waves of ultrasound can be transmitted through any substance containing elastic 
property. The motion of these sounds is transferred to the particles of the environment, 
which vibrate in the route of the ultrasound wave. As the molecules oscillate, the molecular 
distance decreases in the compaction cycle and increases during rarefaction. When the 
molecular distance exceeds the critical amount necessary to hold the liquid perfect, the 
liquid collapse; bubbles and cavities are generated. This procedure (cavitation), refers to the 
generation and the energetic life of bubbles in liquids. The bubbles absorb energy from the 
waves of ultrasound and grow. Then bubble collapse consequences in pressure changes and 
high temperature. The solvent vapor suffers fragmentation to produce reactive particles, such 
as carbenes or free radicals. These high-energy particles are concentrated and lead to 
intermolecular reactions. In general, the yield of product increases, reactions occur faster, 
with lower temperatures and minor percentage of by-products achieved [10]. 
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NEED  of study
The existing synthetic methodologies for [1,3,4] thiadiazoloth [3,2-a]pyrimidinepyrimidine nucleus in a modular cl s i   l r 
fashion are not straightforward and the synthetic routes involve multiple steps. 
For example, 1,3,4-thiadiazolo[3,2thiadiazol [3,2-a]pyrimidinea]pyrimidine-7-sulfonamide derivatives were synthesized from 5sulfonamide derivatives were synthesized from 5-
aminol,3,4-thiadiazolethiadiazole-2-sulfonamide via a two step approach.[11] sulfonamide via a two step ap roach.[11] SalimovSalimov et al.  prepared 2et al. prepared 2-bromobromo-7-methylmethyl-
5-oxo-5H-1,3,41,3,4-thiadiazolo[3,2thiadiazolo[3,2-a]pyrimidinepyrimidine by two steps involving the addition of 2y t  st s i v lvi  t  iti  f -aminothiadiazole aminothiadi zole 
derivatives to ethyl acetoacetateacetoacetate, tandem hydrolysis of the ester to the acid, and , tandem hydrolysi  of the ster to the acid, and cyclizationc to give the ringto give the ring-
fused thiadiazolothiadiazolo[3,2-a]pyrimidinespyrimidines in PPA. in PPA. 
Most of these are multistep protocols, which suffer from generation of by-products, low yields, and use products, low yields, and use 
of metal-containing reagents. containing reagents. 
Therefore, it is quite significant to develop the direct, efficient, and green alternative approaches to get 
the functionalized thiadiazolothiadiazol [3,2-a]pyrimidinepyrimidine derivatives from  the viewpoint of green chemistry. riv tiv s fr   t  vi i t f r  chemistry. 
OBJECTIVE OF STUDY
1. . To design and synthesize the novel, coupled 4-MethylMeth l-7-(3-(4-methylpiperazinmethylpiperazin-1-yl)-3-oxo-1-substitu ed substituted 
phenyl prop-1-en -2-yloxy)yloxy)-2H-chromenr -2-one  derivatives, by fragment joining  using ultrasonic processor. one  derivatives, by fragment joining  using ultrasonic proces or. 
2. . To conduct physicochemical characterization of intermediates and synthesized compounds.
3. . To confirm the structures of synthesized compounds by analytical  and spectral techniques such as TLC, FT-




All the reactions were performed in oven-dried glassware’s. All reagents and solvents were used as obtained from the
supplier or recrystallized /redistilled unless otherwisenoted. The ultrasound sonicator (Sonics Vibra-cell, Modelno.
VCX 500) equipped with solid synthetic probe, 13 mm in tip diameter, operating at 20 kHz with a maximum power
output of 500 W, was used for synthesis of final title compounds. The purity of the synthesized compounds was
monitoredby ascendingthin layerchromatography(TLC) onsilicagel-G (Merck)coatedaluminiumplates,visualized
by iodine vapour and melting points were determined in open capillary tubes. The homogeneity of the compounds was
monitored by ascending thin layer chromatography(TLC) on silica gel-G (Merck) coated aluminium plates, visualized
by iodine vapour.
The1H NMR and13C NMR spectra of synthesized compounds were recorded on Bruker Avance II 400 NMR
Spectrometer at 400 MHz Frequency in deuterated DMSO and CDCl3 and using TMS as internal standard (chemical
shift δ in ppm). Mass spectra of some compounds were scanned on FTMS+p E I full mass (100.00-1500.00).
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General Procedure for the Synthesis of  5-Amino-2-(4-Chlorophenyl)-7- Substituted Phenyl-8,8a-Dihydro-
7H-[1,3,4]Thiadiazolo[3,2-A]Pyrimidine-6-Carbonitrile Derivatives 
Method A: A 25 mL round bottom flask was charged with a mixture of an 5-(4-chlorophenyl )-1,3,4-
thiadiazol-2 amine (0.01mol) , aromatic aldehyde (0.01mol) in ethanol (10-12 ml) and the catalyst NaOH
(20% mmol) and the reaction mixture was refluxed for 1.30-2 h. After completion of the reaction (i.e
formation of Schiff base) as indicated by TLC, malononitrile (0.01mol) was added to the reaction mixture and 
again it was refluxed. . After completion of the reaction (monitored by TLC), the mixture was poured into ice 
cold water. The product obtained, was filtered and dried. The corresponding product was obtained in high 
purity after recrystallization of the crude product from ethanol. The authenticity of compounds was established 
by 1H NMR, 13C NMR, IR and HRMS.
Method B: A 25 mL a beaker was charged with a mixture of an 5-(4-chlorophenyl )-1,3,4-thiadiazol-2 amine 
(0.01mol) , aromatic aldehyde (0.01mol) in ethanol (10-12 ml) and the catalyst NaOH (20% mmol) ) and the 
reaction mixture was kept inside an Ultrasonicator ac ustic chamber at 800C at 20% amplitude for 10-15min. 
After completion of the reaction (i.e formation of Schiff base) as indicated by TLC, malononitrile (0.01mol) 
was added to the reaction mixture and again was kept inside an Ultrasonicator acoustic chamber at 800C at 
20% amplitude for 1-1.30 hrs. After completion of the reaction (monitored by TLC), the mixture was poured 
into ice cold water. The product obtained, was filtered and dried. The corresponding product was obtained in 
high purity after recrystallization of the crude product from ethanol. 
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Identification
Silica gel thin-layer chromatography (TLC)















































Herein we report the one-pot synthesis of novel 5-Amino-2-(4-Chlorophenyl)-7- Substituted Phenyl-8,8a-
Dihydro-7H-[1,3,4]Thiadiazolo[3,2-A]Pyrimidine-6-Carbonitrile Derivatives from three component
reactions of an 5-(4-chlorophenyl )-1,3,4-thiadiazol-2 amine, aromatic aldehydes and malononitrile in the
presence of NaOH under reflux and ultrasonic irradiation asshown inscheme 1.To determine the optimal
reaction conditions, the one pot reactions between 5-(4-chlorophenyl )-1,3,4-thiadiazol-2 amine, aromatic
aldehyde, malononitrile was carried out using different solvents in the presence of NaOH as a catalyst at
different mole percentage as shown in Table 1, the desired pro uct was not formed when H2O was chosen as
solvent andwhenacetonitrile, methanolanddimethylformaidewaschosenassolvent, the desiredproduct
was formed in low yield under reflux and ultrasonic irradiation as shown in Table 1. Proposed mechanism for
the formation of 1,3,4-thiadiazolo[3,2-a]pyrimidine skeleton is as shown in figure 1. All the synthesized
compounds were characterized by1H NMR, 13C NMR, mass spectroscopy and IR. Physical characterization
data of synthesized compound is as shown in table 2.
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Table 2: Optimization of reaction conditions for Novel 5-Amino-2-(4-
Chlorophenyl)-7- Substituted Phenyl-8,8a-Dihydro-7H-[1,3,4]Thiadiazolo[3,2-
A]Pyrimidine-6-Carbonitrile Derivatives using various solvent and different 







Time        yield%
(hrs)
Time           yield%
(hrs)                
1. NO - EtOH 9 - 2 -
catalyst
2. NaOH 30 EtOH 9 70 2 89
3. NaOH 20 EtOH 9 70 2 89
4. NaOH 20 H2O 9 - 2 -
5. NaOH 20 MeOH 11 55 2.30 60
6. NaOH 20 CH3CN 11 40 2.30 50
7. NaOH 20 DMF 12 40 2.30 55
8. NaOH 10 EtOH 13 60 2.45 65
9. NaOH 5 EtOH 15 50 3.30 60
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a 4-chlorophenyl 7 70 1 89
b 2-chlorophenyl 7.30 68 1.30 85
c 3-chlorophenyl 7.30 65 1.30 85
Table 3: Optimization of reaction conditions for 1,3,4-thiadiazolo[3,2-
a]pyrimidine skeleton
d 4-flurophenyl 7 62 1.30 80
e 4-methoxyphenyl 8 58 2 75
f 3,4,5-methoxyphenyl 9 58 2 78
g 3,4-methoxyphenyl 9 55 2 75
h phenyl 7 60 1 80
i 3-hydroxy-4-
methoxyphenyl
9 60 2 82
j 2-furfuraldehyde 8 45 1.30 65
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Figure.1. Proposed mechanismfor the formation of 1,3,4-
thiadiazolo[3,2-a]pyrimidine skeleton
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a 4-chlorophenyl C18H11Cl2N5S 400 237-240 0.28
b 2-chlorophenyl C18H11Cl2N5S 400 240-242 0.24
c 3-chlorophenyl C18H11Cl2N5S 400 235-238 0.20
Table 4: Physical Characterization data of compounds
d 4-flurophenyl C18H11ClFN5S 383 239-242 0.37
e 4methoxyphenyl C19H14ClN5OS 395 210-212 0.37
f 3,4,5-methoxyphenyl C21H18ClN5O3S 455 220-222 0.26
g 3,4-methoxyphenyl C20H16ClN5O2S 425 225-228 0.50
h phenyl C18H12ClN5S 365 218-220 0.43
i 3-hydroxy-4-
methoxyphenyl
C19H14ClN5O2S 411 240-245 0.50
j 2-furfuraldehyde C16H10ClN5OS 355 200-210 0.49
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1. 5-amino-2,7-bis(4-chlorophenyl)-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidine-6-carbonitrile
M.P: 237-240. IR (KBr) cm-1: (C-H Aromatic Stretch) 3000; (C-NH2) 3400 (C-Cl) 740.55 (C=N) 1623
H1NMR δ: 8.00 (d,2H,ArH), 7.51 (d, 2H, ArH), 3.3 (s, 1H, ArCH), 6.79 (d, 2H, ArH), 7.06 (d, 2H, ArH), 10
(s, 2H, amino attached to pyrimidine ring) C13 NMR δ: 172 (CH of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 158
(C of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 143.2(C of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 139.5 (C of
Aromatic ring), 136.5 (C of Aromatic ring), 131 (C of Aromatic ring), 130.5 (C of Aromatic ring), 129.8 (C of
Aromatic ring), 128.5 (C of Aromatic ring), 127.9 (C of Aromatic ring), 118.2 (C of carbonitrile group), 60.2
(C of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 54.5 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine)
2. 5-amino-7-(2-chlorophenyl)-2-(4-chlorophenyl)7H-[1,3,4]thiadiazolo[3,2-a]pyrimidine-6-carbonitrile
M.P: 240-242. IR (KBr) cm-1: (C-H Aromatic Stretch) 3000; (C-NH ) 3400 (C-Cl) 740.55 (C=N) 16232
H1NMR δ: 8.00 (d,2H,ArH), 7.50 (d, 2H, ArH), 3.3 (s, 1H, ArCH), 7.80 (d, 2H, ArH), 7.02, 7.27 (m, 2H,
ArH), 10 (s, 2H, amino attached to pyrimidine ring) C13 NMR δ: 170 (CH of 1,3,4-thiadiazolo[3,2-
a]pyrimidine), 158.3 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 143.7 (C of 1,3,4-thiadiazolo[3,2-
a]pyrimidine), 138.1 (C of Aromatic ring), 134.2 (C of Aromatic ring), 129.5 (C of Aromatic ring), 129 (C of
Aromatic ring), 128.5 (C of Aromatic ring), 127 (C of Aromatic ring), 126 (C of Aromatic ring), 117.5 (C of
carbonitrile group), 60 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 55 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine).
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3. 5-amino-7-(3-chlorophenyl)-2-(4-chlorophenyl)7H-[1,3,4]thiadiazolo[3,2-a]pyrimidine-6-carbonitrile
M.P: 235-238. IR (KBr) cm-1: (C-H Aromatic Stretch) 3000; (C-NH2) 3400 (C-Cl) 740.55 (C=N) 1623
H1NMR δ: 8.00 (d, 2H, ArH), 7.51 (d, 2H, ArH), 3.2 (s, 1H, ArCH), 7.06,7.27, 7.38 (t, 3H, ArH), 7.49 (s,
1H, ArH), 10 (s, 2H, amino attached to pyrimidine ring) C13 NMR δ: 172.2 (CH of 1,3,4-thiadiazolo[3,2-
a]pyrimidine), 158 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 143.5 (C of 1,3,4-thiadiazolo[3,2-
a]pyrimidine), 142.5 (C of Aromatic ring), 136.6 (C of Aromatic ring), 134 (C of Aromatic ring), 129 (C of
Aromatic ring), 128.5 (C of Aromatic ring),128 (C of Aromatic ring), 127 (C of Aromatic ring), 125.5 (C of
Aromatic ring), 117 (C of carbonitrile group), 59 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 53 (C of 1,3,4-
thiadiazolo[3,2-a]pyrimidine). MS; m/z 400.
4. 5-amino-2-(4-chlorophenyl)-7-(4-fluorophenyl)-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidine-6-carbonitrile
M.P: 239-242. IR (KBr) cm-1: (C-H Aromatic Stretch) 3000; (C-NH2) 3400 (C-Cl) 740.55 (C=N) 1623 (C-F)
1053 H1NMR δ: 8.00 (d,2H,ArH), 7.50 (d, 2H, ArH), 3.3 (s, 1H, ArCH), 7.06 (d, 2H, ArH), 7.27 (d, 2H,
ArH), 9.7 (s, 2H, amino attached to pyrimidine ring) C13 NMR δ: 172 (CH of 1,3,4-thiadiazolo[3,2-
a]pyrimidine), 159 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 158 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine),
143.2 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 136.6 (C of Aromatic ring), 136 (C of Aromatic ring), 130.6
(C of Aromatic ring), 129.5 (C of Aromatic ring), 128.9 (C of Aromatic ring), 128.7 (C of Aromatic ring),117
(C of carbonitrile group), 60 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 52 (C of 1,3,4-thiadiazolo[3,2-
a]pyrimidine). MS; m/z 383.
21
5. 5-amino-2-(4-chlorophenyl)-7-(4-methoxyphenyl)-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidine-6-carbonitrile
M.P: 210-212. IR (KBr) cm-1: (C-H Aromatic Stretch) 3000; (C-NH2) 3400; (C-Cl) 740.55; (C=N) 1623; (C-
OCH3) 1055. H
1NMR δ: 8.00 (d, 2H, ArH), 7.50 (d, 2H, ArH), 3.3 (s, 1H, ArCH), 7.06 (d, 2H, ArH),6.79 (d,
2H, ArH), 10 (s, 2H, amino attached to pyrimidine ring), 3.56(s, 3H, methoxy group) C13 NMR δ: 172 (C of
1,3,4-thiadiazolo[3,2-a]pyrimidine), 158(C of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 157.5 (C of Aromatic
ring), 143.5 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine),136 (C of Aromatic ring), 133 (C of Aromatic ring),
130 (C of Aromatic ring), 129.5 (C of Aromatic ring), 128.5 (Cof Aromatic ring), 128 (C of Aromatic ring),
117.3 (C of carbonitrile group), 60 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 55 (C of methoxy group) 53 (C
of 1,3,4-thiadiazolo[3,2-a]pyrimidine). MS; m/z 383
6. 5-amino-2-(4-chlorophenyl)-7-(3,4,5-trimethoxyphenyl)-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidine-6-
carbonitrile
M.P: 220-222. IR (KBr) cm-1: (C-H Aromatic Stretch) 3000; (C-NH2) 3400 (C-Cl) 740.55 (C=N) 1623 (C-
OCH3) 1059. H
1NMR δ: 8.00 (d, 2H, ArH), 7.50 (d, 2H, ArH), 3.3 (s, 1H, ArCH), 6.79 (d, 2H, ArH), 3.56 (s,
9H, methoxy group), 10 (s, 2H, amino attached to pyrimidine ring) C13 NMR δ: 172(CH of 1,3,4-
thiadiazolo[3,2-a]pyrimidine), 158 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 152.8 (C of Aromatic ring),
143(C of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 136.5(C of Aromatic ring), 136 (C of Aromatic ring), 135 (C of
Aromatic ring), 129.5 (C of Aromatic ring), 128.5 (C of Aromatic ring), 128 (C of Aromatic ring), 117.5(C of
carbonitrile group), 106.5 (C of Aromatic ring), 61 (C of methoxy group), 60(C of 1,3,4-thiadiazolo[3,2-
a]pyrimidine) , 56(C of methoxy group), 53 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine). MS; m/z 455 22
7. 5-amino-2-(4-chlorophenyl)-7-(3,4-dimethoxyphenyl)-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidine-6-
carbonitrile
M.P: 225-228. IR (KBr) cm-1: (C-H Aromatic Stretch) 3000; (C-NH2) 3400 (C-Cl) 740.55 (C=N) 1623
(C-OCH3) 1052. H
1NMR δ: 8.00 (d, 2H, ArH), 7.50 (d, 2H, ArH), 3.3 (s, 1H, ArCH), 7.27 (s, 1H, ArH),
7.02- 6.79 (d, 2H, ArH),3.56 (s, 6H, methoxy group), 10 (s, 2Hamino attached to pyrimidine ring) C13
NMR δ: 172(CH of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 158 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine),
149 (C of Aromatic ring), 146 (C of Aromatic ring), 143(C of 1,3,4-thiadiazolo[3,2-a]pyrimidine),
136.5(C of Aromatic ring), 134.5 (C of Aromatic ring), 129.5(C of Aromatic ring), 128.5 (C of Aromatic
ring), 128 (C of Aromatic ring), 122 (C of Aromatic ring), 117.5(C of carbonitrile group), 114 (C of
Aromatic ring), 112.5 (C of Aromatic ring), 60(C of 1,3,4-thiadiazolo[3,2-a]pyrimidine) , 56(C of
methoxygroup), 53 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine). MS; m/z 425
8. 5-amino-2-(4-chlorophenyl)-7-phenyl-7H-[1,3,4]thiad zolo[3,2-a]pyrimidine-6-carbonitrile
M.P: 218-220. IR (KBr) cm-1: (C-H Aromatic Stretch) 3000; (C-NH2) 3400 (C-Cl) 740.55 (C=N) 1623
H1NMR δ: 8.00 (d, 2H, ArH), 7.51 (d, 2H, ArH), 3.2 (s, 1H, ArCH), 7.23 (d, 2H, ArH), 7.33 (d, 2H, ArH),
7.26 (m, 1H, ArH), 10 (s, 2H, amino attached to pyrimidine ring) C13 NMR δ: 172(CH of 1,3,4-
thiadiazolo[3,2-a]pyrimidine), 158 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine) 143.7 (C of 1,3,4-
thiadiazolo[3,2-a]pyrimidine), 141 (C of Aromatic ring),136.5 (C of Aromatic ring), 129.5 (C of Aromatic
ring), 129 (C of Aromatic ring), 128.6 (C of Aromatic ring), 128.5 (C of Aromatic ring), 125.7 (C of
Aromatic ring), 125.6 (C of Aromatic ring), 117.5(C of carbonitrile group), 60 (C of 1,3,4-thiadiazolo[3,2-
a]pyrimidine), 53 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine). MS; m/z 365 23
9. 5-amino-2-(4-chlorophenyl)-7-(3-hydroxy-4-methoxyphenyl)-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidine-6-
carbonitrile
M.P: 240-245. IR (KBr) cm-1: (C-H Aromatic Stretch) 3000; (C-NH2) 3400 (C-Cl) 740.55 (C=N) 1623 (C-
OCH3) 1055 (C-OH) 3333. H
1NMR δ: 8.00 (d, 2H, ArH), 7.51 (d, 2H, ArH), 3.2 (s, 1H, ArCH), 6.86 (s, 1H,
ArCH), 6.68-6.70 (d, 2H, ArCH), 5.35 (s, 1H, hydroxyl group), 3.56 (s, 3H, methoxy group, 10 (s, 2H, amino
attached to pyrimidine ring) C13 NMR δ: 172(CH of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 158 (C of 1,3,4-
thiadiazolo[3,2-a]pyrimidine) 147.1 (C of Aromatic ring), 147 (C of Aromatic ring), 143.7 (C of 1,3,4-
thiadiazolo[3,2-a]pyrimidine), 136.6 (C of Aromatic ring), 134.9 (C of Aromatic ring), 129.5 (C of Aromatic
ring), 128.5 (C of Aromatic ring), 128.5 (C of Aromatic ring), 122.6 (C of Aromatic ring), 117.5(C of
carbonitrile group), 115 (C of Aromatic ring), 112.6 (C of Aromatic ring), 60 (C of 1,3,4-thiadiazolo[3,2-
a]pyrimidine), 53 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine). MS; m/z 411
10.5-amino-2-(4-chlorophenyl)-7-(furan-2-yl)-7H-[1,3,4] thiadiazolo[3,2-a]pyrimidine-6-carbonitrile
M.P: 200-210. IR (KBr) cm-1: (C-H Aromatic Stretch) 3000; (C-NH2) 3400 (C-Cl) 740.55 (C=N) 1623 H
1NMR
δ: 7.58 (d, 2H, furan ring), 7.36(d, 2H, ArH), 7.51 (d, 2H, ArH), 3.5 (s, 1H, ArCH), 6.40 (t, 3H, furan ring), 6.08
(d, 2H, furan ring), 10 (s, 2H, amino attached to pyrimidine ring) C13 NMR δ: 172(CH of 1,3,4-thiadiazolo[3,2-
a]pyrimidine), 158 (C of 1,3,4-thiadiazolo[3,2-a]pyrimidine), 152 (C of furan ring), 143.7 (C of 1,3,4-
thiadiazolo[3,2-a]pyrimidine), 142 (C of furan ring), 136.6 (C of Aromatic ring), 129.5 (C of Aromatic ring),
128.7 (C of Aromatic ring), 128.5 (C of Aromatic ring), 117.5(C of cyno group), 110.6 (C of furan ring), 105 (C















We have developed an efficient one-pot method for the synthesis of 5H-[1,3,4]thiadiazolo[3,2-
a]pyrimidine-6-carbonitrile derivatives under ultrasound irradiation promopted multicomponent
reaction of various aldehyde compounds, 5-(4-chlorophenyl )-1,3,4-thiadiazol-2 amine, and
malononitrile in ethanol using sodium hydroxide as catalys. The present protocol is also extendable to a
wide variety of substrates. The advantages of this protocolare use of ecofriendly catalyst, easy work-up,
ease of product isolation, and high yield. We believe that this method is a useful condensation reaction
for the synthesis of 5H-[1,3,4]thiadiazolo[3,2-a]pyrimidine-6- carbonitrile derivatives.
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